121 related articles for article (PubMed ID: 1352077)
21. Comparative analysis of [3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin's lymphomas.
Veneroni S; Costa A; Motta R; Giardini R; Rilke F; Silvestrini R
Hematol Oncol; 1988; 6(1):21-8. PubMed ID: 3343026
[TBL] [Abstract][Full Text] [Related]
22. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
23. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
[TBL] [Abstract][Full Text] [Related]
24. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
[TBL] [Abstract][Full Text] [Related]
25. Expression of the activation antigen, 4F2, by non-Hodgkin's lymphomas of B-cell phenotype.
Lewandrowski KB; Medeiros LJ; Harris NL
Cancer; 1990 Sep; 66(6):1158-64. PubMed ID: 1698116
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of MDM-2 and p53 expression are associated with high grade non-Hodgkin's lymphomas.
Finnegan MC; Goepel JR; Royds J; Hancock BW; Goyns MH
Cancer Lett; 1994 Nov; 86(2):215-21. PubMed ID: 7982210
[TBL] [Abstract][Full Text] [Related]
28. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
29. Variation of LEF-1 mRNA expression in low-grade B-cell non-Hodgkin's lymphoma.
Howe D; Bromidge T
Leuk Res; 2006 Jan; 30(1):29-32. PubMed ID: 16054689
[TBL] [Abstract][Full Text] [Related]
30. Proliferative activity in non-Hodgkin's lymphomas and chronic lymphocytic leukemias as determined on cytological samples by Ki 67 monoclonal antibody.
Musto P; Melillo L; Lombardi G; Aieta M; Di Renzo N; Carotenuto M
Haematologica; 1990; 75(6):583-4. PubMed ID: 2098303
[No Abstract] [Full Text] [Related]
31. Expression of c-myc p62 Protein in Non-Hodgkin's Lymphomas.
Kittas C; Korkolopoulou P; Pangalis GA; Tsenga A; Boussiotis VA; Spandidos DA
Leuk Lymphoma; 1990; 1(3-4):241-7. PubMed ID: 27463992
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Cohen AM; Grinblat B; Bessler H; Kristt D; Kremer A; Schwartz A; Halperin M; Shalom S; Merkel D; Don J
Leuk Lymphoma; 2004 May; 45(5):951-5. PubMed ID: 15291354
[TBL] [Abstract][Full Text] [Related]
33. [The expression and clinical significance of proliferative antigen Ki-67 and apoptosis-antagonizing antigen Bcl-2 in non-Hodgkin's lymphoma].
Xu W; Sheng R; Zheng Z; Xu T
Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):452-5. PubMed ID: 11798613
[TBL] [Abstract][Full Text] [Related]
34. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
35. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
36. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity.
Yamanaka N; Harabuchi Y; Kataura A
Cancer; 1992 Nov; 70(9):2342-9. PubMed ID: 1394063
[TBL] [Abstract][Full Text] [Related]
38. Assessment of proliferative activity in leukaemic bone marrow using the monoclonal antibody Ki-67.
White DM; Smith AG; Smith JL
J Clin Pathol; 1994 Mar; 47(3):209-13. PubMed ID: 8163690
[TBL] [Abstract][Full Text] [Related]
39. The pattern of Ki-67 and bcl-2 expression in lymphoid malignancies.
Wang PL; Peh SC
Malays J Pathol; 1997 Jun; 19(1):59-64. PubMed ID: 10879243
[TBL] [Abstract][Full Text] [Related]
40. Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells.
Larsson LG; Schena M; Carlsson M; Sällström J; Nilsson K
Blood; 1991 Mar; 77(5):1025-32. PubMed ID: 1899807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
